APA (7th ed.) Citation

L, L., Z, C., Y, Y., & L, Z. (2026). Vaccinia virus for lung cancer therapy: Preclinical progress and prospects as a systemic immunotherapy platform. Frontiers in immunology, 17, 1797922. https://doi.org/10.3389/fimmu.2026.1797922

Chicago Style (17th ed.) Citation

L, Li, Chen Z, Yan Y, and Zhang L. "Vaccinia Virus for Lung Cancer Therapy: Preclinical Progress and Prospects as a Systemic Immunotherapy Platform." Frontiers in Immunology 17 (2026): 1797922. https://doi.org/10.3389/fimmu.2026.1797922.

MLA (9th ed.) Citation

L, Li, et al. "Vaccinia Virus for Lung Cancer Therapy: Preclinical Progress and Prospects as a Systemic Immunotherapy Platform." Frontiers in Immunology, vol. 17, 2026, p. 1797922, https://doi.org/10.3389/fimmu.2026.1797922.